新闻动态 - 道群医药 - - 南京道群健康管理有限公司

PositionHomeNews

News

03-22

2024

Annual sales exceed 3.2 billion, the tenth batch of popular varieties for centralized procurement, and Daoqun's self-developed aspirin enteric coated tablets 100g and 300g have both been evaluated!

Recently, our company's 100mg aspirin enteric coated tablets have passed the drug consistency evaluation, and the National Medical Products Administration has now released the delivery information of ...

Annual sales exceed 3.2 billion, the tenth batch of popular varieties for centralized procurement, and Daoqun's self-developed aspirin enteric coated tablets 100g and 300g have both been evaluated!

06-05

2024

Good news! 奥为舒® Oseltamivir phosphate capsules have been approved for market launch!

【 Warm congratulations 】 The phosphate oseltamivir capsules developed by Nanjing Daoqun Pharmaceutical R&D Co., Ltd. have been approved for market launch!Daoqun Company recently received a Class 4 mar...

Good news! 奥为舒® Oseltamivir phosphate capsules have been approved for market launch!

09-26

2024

Minor inflammation can turn into cancer within a year; these types of inflammation should not be neglected...

"From inflammation to cancer, it actually only takes two or three steps. Many people, when they find inflammation during a physical examination, do not take it seriously, thinking it's a minor issue t...

Minor inflammation can turn into cancer within a year; these types of inflammation should not be neglected...

09-04

2024

You can take the heat, but you don't have to take the ache—don't keep suffering needlessly!

No big deal, just bear it and it will pass. This phrase seems to be a common refrain.Who doesn't have a little ailment or pain? Many times, the word "endure" is our panacea. In the era when most ordin...

You can take the heat, but you don't have to take the ache—don't keep suffering needlessly!

<
1
2
3
4
5
6
7
8
9
10
...
>